GSA Capital Partners »

Sage Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $218k 12k 18.70
2023-12-31 $1.5M 70k 21.67
2023-03-31 $450k 11k 41.97
2022-09-30 $531k 14k 39.17
2022-06-30 $606k 19k 32.32
2021-12-31 $1.1M 26k 42.56
2021-09-30 $371k 8.4k 44.32
2021-06-30 $987k 17k 56.79
2020-12-31 $561k 6.5k 86.48
2020-09-30 $290k 4.7k 61.13
2020-03-31 $614k 21k 28.73
2019-12-31 $445k 6.2k 72.16
2015-06-30 $409k 5.6k 73.04